You must have Credits on your Balance to download this sample
Evidence-Based Practice Project
Pages 15 (3765 words)
Effects of Lowering Blood Glucose v. Standard Treatment in Patients with Diabetes Mellitus Abstract Research shows mixed results for the anticipated therapeutic intervention of intensive glucose lowering in patients with Type 2 diabetes, and whether intensive glucose lowering leads to an impact on major macro and microvascular outcomes.
The study found that the combination of blood glucose lowering and blood pressure medication slows the progression of microvascular complications. Similarly, the Turnbull (2009) meta-analysis study found that intensive glucose control leads to a reduced risk of major cardiovascular events, showing a reduction of 9% for major cardiovascular events. Advance Collaborative (2008) found that intensive blood glucose lowering with gliclazide and other drugs resulted in a reduced incidence of combined major macrovascular and microvascular events, as well as major microvascular events, because there also was a reduction of nephropathy. Still another study suggests that any kind of benefit attained by intensive lowering of blood glucose is lost after one year. The study conducted by Hollman et al. (2008) found that the patients who were assigned intensive glucose lowering were compared to patients who were assigned the standard treatment of dietary restriction. While the immediate results were that the intensive glucose lowering showed that the patients had a lower risk of microvascular complications then the patients with conventional dietary therapy, after one year, these advantages were lost. Introduction Patients with diabetes suffer from a variety of ailments. Among these ailments are microvascular and macrovascular diseases. ...
Not exactly what you need?